Intellia Therapeutics Company
Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.
Investors
Connections from
Headquarters:
Cambridge, Massachusetts, United States
Total Funding:
775000000
Founded Date:
1/1/2014
Employee Number:
251-500
Last Funding Type:
Post-IPO Equity
Investors Number:
9
Last Funding Date:
2021-06-30
Funding Status:
IPO
Estimated Revenue:
$10M to $50M
Industry:
Gene therapy